Similar articles

• Tsikas et al. 15-deoxy-Δ12,14-PGJ2: An interesting but unapproachable pharmacological target [corrected]?

  Tsikas D, Niemann J, Beckmann B. Tsikas D, et al. Int J Cardiol. 2014 Nov 15;177(1):307-9. doi: 10.1016/j.ijcard.2014.08.145. Epub 2014 Aug 30. Int J Cardiol. 2014. PMID: 25217216 No abstract available.
• 15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis.

  Koyani CN, Windischhofer W, Rossmann C, Jin G, Kickmaier S, Heinzel FR, Groschner K, Alavian-Ghavanini A, Sattler W, Malle E. Koyani CN, et al. Int J Cardiol. 2014 May 15;173(3):472-80. doi: 10.1016/j.ijcard.2014.03.086. Epub 2014 Mar 20. Int J Cardiol. 2014. PMID: 24698234 Free PMC article.
• Prostaglandin D2 mediates neuronal protection via the DP1 receptor.

  Liang X, Wu L, Hand T, Andreasson K. Liang X, et al. J Neurochem. 2005 Feb;92(3):477-86. doi: 10.1111/j.1471-4159.2004.02870.x. J Neurochem. 2005. PMID: 15659218
• Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.

  Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J. Ueki S, et al. Int Arch Allergy Immunol. 2007;143 Suppl 1:15-22. doi: 10.1159/000101399. Epub 2007 May 1. Int Arch Allergy Immunol. 2007. PMID: 17541271 Review.
• Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function.

  Sandig H, Pease JE, Sabroe I. Sandig H, et al. J Leukoc Biol. 2007 Feb;81(2):372-82. doi: 10.1189/jlb.0706424. Epub 2006 Oct 17. J Leukoc Biol. 2007. PMID: 17043246 Review.